Dry Eye Syndrome Market Growth Is Accelerating As Industry Transformation Continues
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Dry Eye Syndrome Market Expansion From $4.45 Billion In 2026 To $5.95 Billion In 2030
The market for dry eye syndrome has experienced significant expansion in recent times. Valued at $4.17 billion in 2025, it is projected to reach $4.45 billion by 2026, reflecting a compound annual growth rate (CAGR) of 6.9%. This historical growth has been driven by a higher incidence of dry eye syndrome, an expanding elderly demographic, increased screen time and digital device use, greater public awareness of ocular health, and improvements in artificial tear formulations.
In the coming years, the dry eye syndrome market is anticipated to experience substantial expansion. By 2030, its value is projected to reach $5.96 billion, driven by a compound annual growth rate (CAGR) of 7.5%. This forecasted growth is fueled by factors such as the creation of innovative drug delivery systems, a rise in personalized medicine, increased use of wearable eye care devices, the growth of online pharmacy channels, and heightened research into natural and herbal eye care solutions. Key emerging trends during this period involve advancements in tear film diagnostics, cutting-edge drug delivery platforms, tailored treatments for dry eye, formulations based on natural and herbal ingredients, and the incorporation of wearable eye care technology.
Download A Free Sample Report For Comprehensive Market Insights:
Dry Eye Syndrome Market Expansion Supported By Key Demand Factors
The anticipated expansion of the dry eye syndrome market is expected to be significantly driven by the rising aging demographic. This demographic shift, defined by a higher proportion of elderly individuals within the overall population, directly contributes to market growth, as a larger number of older adults leads to a greater need for efficient treatments and remedies for this common eye condition. For example, data from October 2025 provided by the World Health Organization (WHO), a United Nations (UN) agency headquartered in Switzerland, indicates that by 2030, one out of every six people worldwide will be at least 60 years old, and this age group’s population is forecast to reach 2.1 billion by 2050. Consequently, the increasing aging population is a key factor propelling the dry eye syndrome market forward.
Dry Eye Syndrome Market Segment Analysis: What Are The Major Market Categories?
The dry eye syndrome market covered in this report is segmented –
1) By Product: Liquid Drops, Gel, Liquid Wipes, Eye Ointment, Other Products
2) By Treatment: Corticosteroids, Artificial Tears, Oral Omega Supplements, Lubricating Agent, Other Treatments
3) By Disease Type: Evaporative, Aqueous
4) By Distribution Channel: Offline, Online
5) By Application: Hospitals And Clinics, Medical Laboratories, Other Applications
Subsegments:
1) By Liquid Drops: Preservative-Free Drops, Preserved Liquid Drops, Antibiotic-Infused Drops
2) By Gel: Long-Lasting Gels, Hydrogel Formulations
3) By Liquid Wipes: Pre-Moistened Wipes, Anti-Bacterial Wipes
4) By Eye Ointment: Night-Time Ointments, Therapeutic Ointments
5) By Other Products: Eye Masks, Contact Lens Solutions, Nutritional Supplements
Dry Eye Syndrome Market Growth Trends Influencing Competitive Dynamics
Major players in the dry eye syndrome market are concentrating on creating cutting-edge solutions like nanomicellar drug delivery technology to boost treatment efficacy and improve patient ease. This technology employs tiny micelles to enhance the penetration of active compounds into ocular tissues, enabling quicker therapeutic effects. It seeks to overcome the shortcomings of current therapies and fulfill the significant unmet demand in dry eye disease. For example, in April 2023, Sun Pharma, a pharmaceutical firm based in India, introduced CEQUA, which utilizes NCELL nanomicellar technology. This product represents the first dry eye treatment in India delivered via this method, offering superior delivery compared to cyclosporine emulsion 0.05 percent. Supported by extensive clinical experience in the United States and other regions, it delivers faster outcomes and maintains good patient comfort from the onset of therapy. This launch addresses the rising incidence of dry eye disease in India, where increased screen time is driving higher case numbers and an anticipated growth in disease burden over the coming years.
Dry Eye Syndrome Market Leading Companies Driving Competitive Growth
Major companies operating in the dry eye syndrome market are Allergan plc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Santendo Pharmaceutical Co. Ltd., Sentiss Pharma Pvt. Ltd., Johnson & Johnson, Alcon Vision LLC, Akorn Operating Company LLC, Sun Pharmaceutical Industries Ltd., Bausch Health Companies Inc., AbbVie Inc., I-MED Pharma Inc., AFT Pharmaceuticals, Horus Pharma, Novaliq GmbH, OASIS Medical, Prestige Consumer Healthcare, VISUfarma, Alimera Science, Kala Pharmaceuticals Inc., Nicox S.A., EyeGate Pharmaceuticals Inc., ReVision Therapeutics Inc., Itear Medical
Access The Complete Dry Eye Syndrome Market Report:
Dry Eye Syndrome Market Largest Region By Revenue And Market Share
North America was the largest region in the dry eye syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global dry eye syndrome market report during the forecast period. The regions covered in the dry eye syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
